Adolor Corporation to Host Investor Conference Call to Discuss the FDA Approval of Entereg(R) (alvimopan)

21 May 2008

·www.biospace.com

EXTON, Pa.--(BUSINESS WIRE)--Adolor Corporation (NASDAQ:ADLR) will be hosting an investor conference call and webcast on Wednesday, May 21, 2008 at 8:30 a.m. Eastern Time to discuss the U.S. Food and Drug Administration (FDA) approval of Entereg® (alvimopan) capsules to help patients regain gastrointestinal function earlier following bowel resection surgery.

Organizations

Adolor Corp.

Indications

Targets

Drugs

Alvimopan Dihydrate

Chat with Hiro

Hot reports

GPRC5D Target Patent Research Report

Patsnap Synapse

Global Drug R&D Express (July 2024)

PatSnap Synapse

siRNA Drug Amvuttra Patent Research and Practical Operation Guide

Patsnap Synapse

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.